A Short Report From Courtney Miller on Dr. Nath's CDC Grand Rounds Presentation on the NIH's Clinical Trial
(Full blog later)
Stringent Diagnostic Criteria: The study will draw its patients from ME/CFS experts and have stringent diagnostic criteria.
[/fright]Nath believes that an infection alters immune functioning which then whacks the brain.
(Full blog later)
"We believe this work will allow therapies to be identified" Dr. Avindra Nath
Stringent Diagnostic Criteria: The study will draw its patients from ME/CFS experts and have stringent diagnostic criteria.
- enrollment criteria include Canadian Consensus Criteria, PEM
- infectious onset is required
- enroll from expert clinical sites in CDC multi-site study (those include: Peterson, Klimas, Lapp, Bateman, Podell, Kogelnik, Natelson)
- His focus will be on immune dysfunction"
- The hypothesis of study is that post-infectious ME/CFS is triggered by viral infection which results in immune mediated brain dysfunction
- He believes that viral onset patients are likely to have similar immune profile
- It will analyze 1500 analytes (cytokines/chemokines) and 2500 proteins)
- They hope to identify the cell or cells that are dysfunctional and causing ME/CFS and explore them deeply
- They will also study neurological changes before and after exercise and hope to develop an animal model
- functional MRI's
- Metabolic studies
- transcranial magnetic stimulation and
- autonomic nervous system functioning
- 3 Phase study: Ph 1 phenotype, Ph 2 validate biomarkers, Ph 3 intervention study with immunomodulatory agent targeting biomarkers
Last edited: